Long-term safety and tolerability of lumateperone 42 mg in patients with stable symptoms of schizophrenia: Results from a 1-year open-label study.

Christoph U Correll; Suresh Durgam; Susan G Kozauer; Changzheng Chen; Willie R Earley

doi:10.1016/j.schres.2026.08.030

SCHEDA SCIENTIFICA2026Altra ricerca

Long-term safety and tolerability of lumateperone 42 mg in patients with stable symptoms of schizophrenia: Results from a 1-year open-label study.

Christoph U Correll, Suresh Durgam, Susan G Kozauer, Changzheng Chen, Willie R Earley

Schizophrenia research · 2026

Psicopatologia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansSchizophreniaFemaleMaleAdultAntipsychotic AgentsMiddle AgedProlactinYoung AdultButyrophenonesPsychiatric Status Rating ScalesTreatment OutcomeHeterocyclic Compounds, 4 or More RingsLong-termLumateperoneOpen-labelSafety

Come citare questo studio

Christoph U Correll, Suresh Durgam, Susan G Kozauer, Changzheng Chen, Willie R Earley. (2026). Long-term safety and tolerability of lumateperone 42 mg in patients with stable symptoms of schizophrenia: Results from a 1-year open-label study.. Schizophrenia research. DOI: 10.1016/j.schres.2026.08.030

Consulta la pubblicazione originale ↗